NL-OMON42559
Withdrawn
Not Applicable
Personalized Treatment Management and Prognosis in Psychiatry: A feasibility Study - Personalized Treatment and Prognosis in Psychiatry: feasibility Study
GGZ Centraal (Amersfoort)0 sites45 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Mental Disorder
- Sponsor
- GGZ Centraal (Amersfoort)
- Enrollment
- 45
- Status
- Withdrawn
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Page 15 of research protocol:
- •\* Minimum age of 18 years, recent\-onset affective/psychotic psychopathology, and sufficient command of the Dutch language.
- •\* Is mentally competent (wilsbekwaam) according the algorithm from the Royal Dutch Medical Association (KNMG) , i.e. the patient is able to make choices, understands medical information, can apply this to his/her own situation, and whether he/she is able to logically consider the choice. (Mental incompetence is a legally defined status \* there is no straightforward relation between mental incompetence and the underlying diagnosis).
Exclusion Criteria
- •Page 16 of research protocol:
- •\* A history of neurological disorder impacting motor/cognitive/mental function
- •\* GAF\-score below 45
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Proactive patient-centred treatment planning with chronically sick older patientsHealth and everyday life problems as assessed by the STEP-assessmentother volunteered health problemsDRKS00000792Institut für AllgemeinmedizinMedizinische Hochschule Hannover332
Not yet recruiting
Not Applicable
Personalized, predictive, precise & preventive medicine for Major DepressioMajor Depressive Disorder MDD (DSM-5) / rezidivierende depressive Störung, gegenwärtig mittelgradig bis schwer (ICD-10: F32.1-3 & F33.1-3) and/or Persistend Depressive Disorder (PDDICD-10: F34.1)F32F33F34.1Depressive episodeRecurrent depressive disorderDysthymiaDRKS00032215Medizinische Hochschule Hannover1,000
Active, not recruiting
Phase 1
Trial investigating a personalized treatment, based on age and tumor characteristics , of newly diagnosed medullablastoma in patients that are postpubertal and/or adult consisting of lowering RT,chemotherapy doses and adding an investigative drug.EUCTR2020-003063-26-FREuropean Organisation for Research and Treatment of205
Withdrawn
Not Applicable
Personalised and contingency-based interventions for suicide risk.ACTRN12621001680853Open Arms - Veterans & Families Counselling2,000
Not yet recruiting
Phase 4
Treatment of neovascular AMD: Artificial intelligence in real-world setting2024-518482-99-01Medical University Of Vienna290